Featured Research

from universities, journals, and other organizations

Does A Component Of Niacin Point The Way To Anti-aging Drugs?

Date:
February 10, 2007
Source:
The Wistar Institute
Summary:
In recent years, scientists have discovered that a family of enzymes called sirtuins can dramatically extend life in organisms as diverse as yeast, worms and flies. A number of scientific groups and biotechnology companies are eagerly searching for drug candidates able to boost sirtuin activity, hoping to develop an "anti-aging" drug. Now, a new study from scientists at the Wistar Institute points to another strategy for activating sirtuins to unleash their anti-aging powers.

In recent years, scientists have discovered that a family of enzymes called sirtuins can dramatically extend life in organisms as diverse as yeast, worms, and flies. They may also be able to control age-associated metabolic disorders, including obesity and type II diabetes.

Related Articles


Naturally occurring substances have been shown to activate sirtuins, including a constituent of red wine called resveratrol -- although an individual would need to drink about two cases of wine a day to derive a clinically effective dose of resveratrol. Still, the findings have energized a number of scientific groups and biotechnology companies, all of which are now eagerly searching for drug candidates able to boost sirtuin activity. The public-health benefits of such an "anti-aging" drug would be substantial -- as would the economic returns.

Now, a new study from scientists at The Wistar Institute points to another strategy for activating sirtuins to unleash their anti-aging powers. A report on the research will appear in the February 9 edition of Molecular Cell, and a podcast interview with the study's senior author, Ronen Marmorstein, Ph.D., a professor in the Gene Expression and Regulation Program at Wistar, will be available on the Institute's web site (http://www.wistar.org) on the same date.

Using the techniques of structural biology, the Wistar team demonstrated that a component of the common vitamin B3, also known as niacin, binds to a specific site on the sirtuin molecule to inhibit its activity. This observation suggests that drugs designed to prevent the vitamin B3 component, nicotinamide, from binding at this site could have the effect of activating sirtuins. Any such drug would, in essence, inhibit the inhibitory effect of nicotinamide. As in mathematics, the two negatives would create a positive result -- activation of sirtuins.

"Our findings suggest a new avenue for designing sirtuin-activating drugs," says Marmorstein. "The jury is still out as to whether a drug of this kind might result in longer life in humans, but I'm equally excited by the possibility that such interventions might help counteract age-related health problems like obesity and type II diabetes."

The nicotinamide binding site may be a particularly attractive drug target for other reasons too, according to Marmorstein. His group now hopes to use rational drug design techniques to create such a drug.

"Many drugs have unwanted side effects because in addition to the intended target, the drugs also hit other biologically active molecules that you don't want to affect," he says. "This nicotinamide-binding site we've identified appears to be unique to the sirtuins, so that if we're able to design a molecule to target it, it should be very specific for these sirtuin molecules."

Marmorstein's research on sirtuins also links to a long line of observations concerning calorie-restricted diets and longevity.

"People have known for some time that low-calorie diets result in life extension in many organisms, but they didn't know why," he says. "Recent research has shown that the connection works at least in part through these sirtuin molecules."

The lead author on the Molecular Cell study is Brandi D. Sanders at The Wistar Institute. Kehao Zhao, Ph.D., formerly at Wistar and now at the Novartis Institutes for Biomedical Research Inc. in Cambridge, Massachusetts, is also a coauthor, as is James T. Slama, Ph.D., with the College of Pharmacy at the University of Toledo, Ohio. Funding to support the research was provided by the National Institutes of Health and the Commonwealth Universal Research Enhancement Program of the Pennsylvania Department of Health.


Story Source:

The above story is based on materials provided by The Wistar Institute. Note: Materials may be edited for content and length.


Cite This Page:

The Wistar Institute. "Does A Component Of Niacin Point The Way To Anti-aging Drugs?." ScienceDaily. ScienceDaily, 10 February 2007. <www.sciencedaily.com/releases/2007/02/070208131737.htm>.
The Wistar Institute. (2007, February 10). Does A Component Of Niacin Point The Way To Anti-aging Drugs?. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/2007/02/070208131737.htm
The Wistar Institute. "Does A Component Of Niacin Point The Way To Anti-aging Drugs?." ScienceDaily. www.sciencedaily.com/releases/2007/02/070208131737.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com
From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

Newsy (Nov. 25, 2014) The US FDA is announcing new calorie rules on Tuesday that will require everywhere from theaters to vending machines to include calorie counts. Video provided by Newsy
Powered by NewsLook.com
Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Newsy (Nov. 25, 2014) Need another reason to eat yogurt every day? Researchers now say it could reduce a person's risk of developing type 2 diabetes. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins